Literature DB >> 17699324

Aldosteronism and hypertension.

David A Calhoun1.   

Abstract

A growing body of evidence suggests that hyperaldosteronism contributes significantly to the development and the severity of hypertension as well as to resistance to antihypertensive treatment. In cross-sectional analyses, plasma aldosterone levels have been shown to relate to BP levels, particularly in obese individuals. In these same individuals, BP was not related to plasma renin activity, suggesting an effect of aldosterone on BP independent of renin-angiotensin II. In a recent prospective analysis from the Framingham investigators, baseline serum aldosterone was strongly associated with development of hypertension during a 4-yr follow-up.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17699324     DOI: 10.2215/CJN.01060306

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  20 in total

1.  Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

Authors:  Alessia Buglioni; Valentina Cannone; Alessandro Cataliotti; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Paolo Dessì-Fulgheri; Riccardo Sarzani; John C Burnett
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Essential role of ICAM-1 in aldosterone-induced atherosclerosis.

Authors:  Vincenzo Marzolla; Andrea Armani; Caterina Mammi; Mary E Moss; Vittoria Pagliarini; Laura Pontecorvo; Antonella Antelmi; Andrea Fabbri; Giuseppe Rosano; Iris Z Jaffe; Massimiliano Caprio
Journal:  Int J Cardiol       Date:  2017-01-05       Impact factor: 4.164

Review 3.  Polychlorinated biphenyls and links to cardiovascular disease.

Authors:  Jordan T Perkins; Michael C Petriello; Bradley J Newsome; Bernhard Hennig
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-17       Impact factor: 4.223

4.  Primary hyperaldosteronism presenting as persistent postpartum hypertension: Illustrative case and systematic review.

Authors:  Caitlin Kilmartin; Touhid Opu; Tiina Podymow; Natalie Dayan
Journal:  Obstet Med       Date:  2018-05-22

5.  Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Authors:  Anthony G Garcia; Richard M Wilson; Joline Heo; Namita R Murthy; Simoni Baid; Noriyuki Ouchi; Flora Sam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

6.  Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.

Authors:  Matthew Fomonyuy Yuyun; Sandeep K Jutla; Paulene A Quinn; Leong L Ng
Journal:  Heart Asia       Date:  2012-08-24

7.  Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.

Authors:  H Wang; C Weng; H Chen
Journal:  J Hum Hypertens       Date:  2017-01-19       Impact factor: 3.012

8.  Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma.

Authors:  Ra Mi Kim; Jandee Lee; Euy-Young Soh
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

9.  Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.

Authors:  Flora Sam; Toni-Ann S Duhaney; Kaori Sato; Richard M Wilson; Koji Ohashi; Saki Sono-Romanelli; Akiko Higuchi; Deepa S De Silva; Fuzhong Qin; Kenneth Walsh; Noriyuki Ouchi
Journal:  Endocrinology       Date:  2009-10-22       Impact factor: 4.736

10.  Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systems.

Authors:  Yvette Carter; Madhuchhanda Roy; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2012-08-15       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.